Picard Medical, Inc. (AMEX: PMI) is a Healthcare company (Medical - Devices) with a market capitalization of $751M. The Maz Rating grades it against the other companies in its sector.
Picard Medical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $7.31, Picard Medical, Inc. trades at 139.5x sales and 12.8x book value. Over the last twelve months it generated about $5M of revenue and a net loss of $1.2B. It runs a gross margin of 33.8%, an operating margin of -258.7% and a net margin of -371.2%. It shows return on equity of -1469.0%, return on invested capital of -488.7% and a free cash flow yield of -1.6%. On the balance sheet: a debt-to-equity ratio of 1.12 and a current ratio of 0.99. Over the past 52 weeks the share price ranged from $2.65 to $208.00, with a beta of -2.76.
Picard Medical, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.